News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Highlights of the RADIOSA phase II trial presented at ESTRO24
Photo from ESTRO/LinkedIn
Jul 5, 2024, 01:49

Highlights of the RADIOSA phase II trial presented at ESTRO24

European Society for Radiotherapy and Oncology (ESTRO) shared a paper on LinkedIn:

“Highlights of the RADIOSA phase II trial presented at ESTRO24: SBRT + short-term ADT significantly improves outcomes in oligorecurrent hormone-sensitive prostate cancer patients.

Report by Simon Spohn.”

Read further.
Source: ESTRO/LinkedIn

.

cancer ESTRO ESTRO24 hormone-sensitive prostate cancer OncoDaily Oncology prostate cancer prostate cancer patients RADIOSA trial radiotherapy Simon Spohn
Special Coverage
Blog
Feb 21, 2025, 09:07
Karen Knudsen: Integrating technology into clinical practice
Blog
Feb 21, 2025, 09:00
ICCD 2025 Event Highlights: Speakers’ Quote Series - SIOP Europe
Blog
Feb 21, 2025, 08:48
Emily Drake: Delivery of palliative and end-of-life care for AYAs living with cancer
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer
Blog
Feb 21, 2025, 06:10
Afreen Shariff: Start-ups are about persistence, grit and being comfortable with being uncomfortable
Radiotherapy
Feb 21, 2025, 04:51
Radiotherapy For Breast Cancer: Types, Success Rate, Side Effects And More
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy
Blog
Feb 20, 2025, 11:13
Abstract submissions are open for the ESMO Gynae25